Skip to main content
Clinical Trials/NCT06486233
NCT06486233
Recruiting
Not Applicable

Comparison of Mortality and Complication Rates (Re-myocardial Infarction, Heart Failure, Re-hospitalization, Stroke) After 12 Months Between Two Groups of Patients Undergoing Early Invasive and Late Invasive Strategies in Patients With Elderly Patients With High - Risk Non-ST-segment Elevation Acute Coronary Syndrome.

Gia Dinh People Hospital1 site in 1 country385 target enrollmentFebruary 22, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myocardial Infarction
Sponsor
Gia Dinh People Hospital
Enrollment
385
Locations
1
Primary Endpoint
In-hospital death
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The goal of this is observational study is to compare about MACE events and predisposing factors related to MACE events in elderly patients with high-risk non-ST acute coronary syndromes receiving early versus late invasive treatment . This study will anwser two questions.

Question 1: What will factors associate with implementing a late invasive strategy in elderly patients with high-risk non-ST-segment elevation acute coronary syndrome ? Question 2: Is a meaningful difference about mortality and complication rates as re-myocardial infarction, heart failure, re-hospitalization, stroke after 12 months between two groups of patients undergoing early invasive and late invasive strategies in elderly patients with in high-risk non-ST-segment elevation acute coronary syndrome?

Registry
clinicaltrials.gov
Start Date
February 22, 2024
End Date
March 1, 2028
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Gia Dinh People Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • aged 60 years and older
  • high - risk non-ST-segment elevation acute coronary syndrome (according to the 2023 European Heart Association recommended standards).
  • receives reperfusion intervention.

Exclusion Criteria

  • Acute coronary syndrome due to stent thrombosis, or coronary artery bypass graft occlusion.
  • Incomplete medical records.

Outcomes

Primary Outcomes

In-hospital death

Time Frame: one month

recorded when death occurs during treatment or is confirmed by in-hospital monitoring

Secondary Outcomes

  • after 12 months death(one year)
  • MACE after 12 months include re-admission, recurrent myocardial infarction , stroke, heart failure(one year)

Study Sites (1)

Loading locations...

Similar Trials